We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $5.65B
1-Year Est. Return 61.31%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+61.31%
3 Year Est. Return
+139.52%
5 Year Est. Return
+178.85%
10 Year Est. Return
+707.09%
AUM
$4.72B
AUM Growth
-$29.5K
Cap. Flow
-$108M
Cap. Flow %
-2.29%
Top 10 Hldgs %
8.96%
Holding
582
New
51
Increased
231
Reduced
239
Closed
47

Top Buys

Rank Stock Value
1
TEX icon
Terex
TEX
+$35.8M
2
RAL
Ralliant Corp
RAL
+$35.5M
3
ALGM icon
Allegro MicroSystems
ALGM
+$29.8M
4
MCB icon
Metropolitan Bank Holding Corp
MCB
+$18.7M
5
RXO icon
RXO
RXO
+$14.3M

Sector Composition

Rank Sector Weight
1 Industrials 20.13%
2 Healthcare 19.35%
3 Financials 19.35%
4 Technology 12.31%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVO icon
501
LiveOne
LVO
$53.1M
$785K 0.02%
+153,953
New +$746K
CGEM icon
502
Cullinan Oncology
CGEM
$1.4B
$732K 0.02%
51,491
+4,225
+9% +$54.3K
TRVI icon
503
Trevi Therapeutics
TRVI
$2.39B
$731K 0.02%
61,298
+5,029
+9% +$56.3K
IWC icon
504
iShares Micro-Cap ETF
IWC
$1.5B
$724K 0.02%
+4,537
New +$753K
MMSI icon
505
Merit Medical Systems
MMSI
$5.4B
$716K 0.02%
10,384
-455
-4% -$35.5K
NTRA icon
506
Natera
NTRA
$47B
$701K 0.01%
3,503
+288
+9% +$62K
FRME icon
507
First Merchants
FRME
$2.63B
$700K 0.01%
+18,075
New +$706K
HCAT icon
508
Health Catalyst
HCAT
$120M
$647K 0.01%
509,782
-455,007
-47% -$856K
AMRX icon
509
Amneal Pharmaceuticals
AMRX
$6.11B
$634K 0.01%
+50,977
New +$684K
VTRS icon
510
Viatris
VTRS
$18.8B
$625K 0.01%
+46,257
New +$647K
ELV icon
511
Elevance Health
ELV
$85.5B
$553K 0.01%
1,888
-83
-4% -$27.3K
GLUE icon
512
Monte Rosa Therapeutics
GLUE
$1.14B
$526K 0.01%
+31,977
New +$612K
SPSC icon
513
SPS Commerce
SPSC
$3.06B
$499K 0.01%
8,968
-90
-1% -$6.49K
SION
514
Sionna Therapeutics
SION
$265M
$492K 0.01%
12,284
+5,532
+82% +$211K
MDXH icon
515
MDxHealth
MDXH
$68.8M
$473K 0.01%
205,438
-189,942
-48% -$645K
RNA
516
Atrium Therapeutics
RNA
$233M
$454K 0.01%
+33,977
New +$477K
CADL icon
517
Candel Therapeutics
CADL
$1B
$454K 0.01%
+92,625
New +$504K
QRHC icon
518
Quest Resource Holding
QRHC
$30M
$388K 0.01%
326,225
+6,349
+2% +$11.1K
NTLA icon
519
Intellia Therapeutics
NTLA
$1.8B
$377K 0.01%
29,424
+2,415
+9% +$30.8K
VLO icon
520
Valero Energy
VLO
$101B
$367K 0.01%
1,485
-8
-0.5% -$1.65K
RTX icon
521
RTX Corp
RTX
$285B
$294K 0.01%
1,524
-431
-22% -$85.7K
JPM icon
522
JPMorgan Chase
JPM
$951B
$274K 0.01%
932
-6
-0.6% -$1.82K
GS icon
523
Goldman Sachs
GS
$301B
$266K 0.01%
314
-1
-0.3% -$892
FHN icon
524
First Horizon
FHN
$11.7B
$253K 0.01%
11,132
-62
-0.6% -$1.48K
XEL icon
525
Xcel Energy
XEL
$47.8B
$243K 0.01%
3,057
-17
-0.6% -$1.33K

Similar funds

Kennedy Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Kennedy Capital Management held 582 positions worth $4.72B, down 0% from $4.72B the previous quarter. Its ten largest holdings account for 9% of the portfolio.

Kennedy Capital Management's Q1 2026 filing shows 51 new, 231 increased, 239 reduced and 47 closed positions. Its largest new stake was Terex: 577,450 shares worth $34.1M. The largest sale was REV Group, an estimated $31.5M.

By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Kennedy Capital Management's largest Q1 2026 buy was Terex: 577,450 shares worth $34.1M.
  • Kennedy Capital Management added most to Allegro MicroSystems in Q1 2026, an estimated $29.8M increase.
  • Kennedy Capital Management's biggest Q1 2026 reduction was MKS Inc, cutting an estimated $24.3M.
  • Kennedy Capital Management fully exited REV Group in Q1 2026, selling an estimated $31.5M.
  • Kennedy Capital Management's ten largest holdings make up 9% of its $4.72B portfolio in Q1 2026.
  • Kennedy Capital Management opened 51 new positions and closed 47 in Q1 2026.
  • Kennedy Capital Management's portfolio value fell 0% quarter-over-quarter to $4.72B.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.